课题基金 / 基金详情

Developmental Research Projects Program (DRPP)

Developmental Research Projects Program (DRPP)
发展研究项目计划(DRPP)
批准号:
10451486
负责人:
SURANGANIE DHARMAWARDHANE
金额:
$238.45万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
未结题
起止时间:
2001-09-15 至 2026-06-30

项目摘要

项目成果

SURANGANIE DHARMAWARDHANE的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 发展研究项目计划(DRPP)的总体目标是支持职业 在PR-INBRE牵头机构和网络机构发展有前途的早期调查人员。DRPP是 通过提供指导和财政支持来加强研究,是PR-INBRE成功的核心 网络的容量。我们将使用在当前阶段建立的基础架构和协议 周期:宣传DRPP资金和指导机会,严格的同行审查程序,以及 涉及INBRE行政核心、指导委员会(SC)、外部 咨询委员会(EAC)和美国国立卫生研究院项目办公室。DRPP将确定有前途的调查人员 职业生涯的早期阶段和博士后伙伴,并为他们提供不仅经济支持,而且 通过以下具体目标提供个性化的指导和具有凝聚力的研究基础设施。第一,要 增加和发展公关人才库、结构化的指导计划和相关的发展 将实施各项活动,重点是落实个人发展计划和 加强文风建设和写作技巧。第二,扭转联邦资源普遍下降的局面 生物医学研究,我们将为提出使用循证医学的有价值的研究提供资金 改善人类健康和填补我们目前在以下主题领域的知识库中的重大空白的调查结果 神经科学/行为学、分子医学/癌症、药物发现/开发和生物信息学。第三, PR-INBRE的研究基础设施将得到有限的小型仪器奖的支持 PUIS的教学和科研需求。这一目标还将向INBRE颁发合作迷你奖项 调查人员将增加INBRE核心设施的使用,用于PR-OMICS和大数据型研究- INBRE中央研究仪器核心(CRI)和生物信息学资源核心(BIRC)。AS 我们目前成功地获得了R类资金和由DRPP进行同行评审的出版物,这表明了这一点 调查人员,结果将通过内部和外部评估和跟踪成功的赠款来衡量 和稿件的提交以及独立资助的实现。因此,这些目标旨在 鼓励INBRE和Cobre机构之间的跨学科研究,增加 授予DRPP调查人员的外部资金,提高了PR-INBRE调查人员的质量 出版,并指导合格的调查人员通过R15和R21奖项获得独立资金。 这些战略预计最终将导致一支训练有素、代表性不足的科学家队伍。 促进健康福利和增加生物医学科学的多样性。因此,DRPP预计将 组织、建立和开发激励、高效和协作的研究计划 加强我们在国家和国际层面上争夺研究显赫地位的能力。
英文摘要
Project Summary The overall goal of the Developmental Research Project Program (DRPP) is to support the career development of promising early stage investigators at PR-INBRE lead and network institutions. The DRPP is central to the success of the PR-INBRE by providing mentoring and financial support to enhance the research capacity of the network. We will use the infrastructure and protocols that were established during the current cycle for: publicizing the DRPP funding and mentoring opportunities, the rigorous peer-review procedure, and the funding decision process involving the INBRE Administrative Core, Steering Committee (SC), External Advisory Committee (EAC), and the NIH Program Office. The DRPP will identify promising investigators in the early stages of their careers and postdoctoral associates, and provide them with not just financial support, but individualized mentoring and a cohesive research infrastructure by the following Specific Aims. First, to increase and develop the talent pool in PR, a structured mentoring program and related developmental activities will be implemented, with an emphasis on fulfillment of Individual Developmental Plans (IDP) and reinforcing grantsmanship and writing skills. Second, to reverse the general decline in federal resources for biomedical research, we will provide funds for meritorious research that proposes to use evidence-based findings to improve human health and fill critical gaps in our current knowledge base in the thematic areas of Neuroscience/Behavior, Molecular Medicine/Cancer, Drug Discovery/Development, and Bioinformatics. Third, the research infrastructure of the PR-INBRE will be buttressed by limited awards for small instruments for teaching and research needs of the PUIs. This Aim will also grant collaborative mini awards to INBRE investigators to augment the use of INBRE Core facilities for “OMICS” and big-data type studies at the PR- INBRE Centralized Research Instrumentation Core (CRI) and the Bioinformatics Resources Core (BiRC). As shown by our current success in obtaining R-type funding and peer-reviewed publications by the DRPP investigators, outcomes will be measured by internal and external Evaluation and Tracking of successful grant and manuscript submission and achievement of independent funding. Therefore, these Aims are designed to encourage interdisciplinary research among the INBRE and COBRE institutions, increase the number of extramural funds awarded to the DRPP investigators, augment the quality of PR-INBRE investigators’ publications, and mentor qualified investigators to obtain independent funding through R15 and R21 awards. These strategies are expected to result in a highly trained cadre of underrepresented scientists ultimately contributing to health benefits and increased diversity in the biomedical sciences. Thus, the DRPP expects to organize, establish, and develop a stimulating, highly productive, and collaborative research program that will strengthen our capabilities to compete for research prominence at the national and international level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MBQ-167 derivatives as antimetastatic cancer agents.
Molecular targets of soy isoflavones in breast cancer progression
CANCER RESEARCH CENTER
  • 批准号:
    8166211
  • 项目类别:
  • 资助金额:
    $18.74万
  • 财政年份:
    2010
  • 负责人:
    SURANGANIE DHARMAWARDHANE
  • 依托单位:
Targeting breast cancer progression
海外基金